安进Amgen Inc. (AMGN) 2000年年度报告「NASDAQ」.pdf

1、Amgen 2000 Annual Reportdramatically improving peoples livesvitality freedomdetermination confidenceindependence agilityContentsSelected Financial InformationLetter to the ShareholdersChronic Kidney DiseaseCancerRheumatoid ArthritisProducts and Product CandidatesManagements Discussion and Analysis o

2、f Financial Condition and Results of OperationsQuantitative and Qualitative Disclosures about Market RiskConsolidated Financial StatementsReport of Ernst&Young LLP,Independent AuditorsOperating SubsidiariesBoard of Directors and Executive OfficersCorporate Information241416182022272845464748We aspir

3、e to be the best human therapeutics company.We will live the Amgen Valuesand use science and innovation to dramatically improvepeoples lives.Consolidated Statement of Operations Data(In millions,except per share data)Years ended December 31,20001999 1998 199719961995 1994 1993 1992 1991Revenues:Prod

4、uct sales1$3,202.2$3,042.8$2,514.4$2,219.8$2,088.2$1,818.6$1,549.6$1,306.3$1,050.7$645.3Other revenues 427.2 297.3203.8 181.2 151.6121.3 98.3 67.5 42.3 36.7Total revenues 3,629.4 3,340.1 2,718.2 2,401.0 2,239.81,939.9 1,647.9 1,373.8 1,093.0 682.0Research and development expenses 845.0 822.8 663.3 6

5、30.8 528.3451.7 323.6 255.3 182.3 120.9Selling,general,and administrative expenses 826.9 654.3 515.4 483.8 470.6418.4 359.8 328.4 292.2 202.6Other items,net2(18.8)(49.0)(23.0)157.0 116.4(13.9)(77.1)129.1Net income 1,138.5 1,096.4 863.2 644.3 679.8537.7 319.7 383.3 357.6 97.9Diluted earnings per shar

6、e 1.05 1.02 0.82 0.59 0.610.48 0.29 0.33 0.30 0.08Cash dividends per share Consolidated Balance Sheet Data(In millions)At December 31,20001999 1998 1997 1996 1995 1994 1993 1992 1991Total assets$5,399.6$4,077.6$3,672.2$3,110.2$2,765.6$2,432.8$1,994.1$1,765.5$1,374.3$865.5Long-term debt 223.0 223.0 2